Ryan Halsted

Stock Analyst at RBC Capital

(0.80)
# 5,150
Out of 5,182 analysts
14
Total ratings
22.22%
Success rate
-9.62%
Average return

Stocks Rated by Ryan Halsted

Medpace Holdings
Apr 24, 2026
Maintains: Outperform
Price Target: $522$484
Current: $409.65
Upside: +18.15%
Healthcare Services Group
Apr 23, 2026
Maintains: Sector Perform
Price Target: $22$24
Current: $21.57
Upside: +11.27%
Doximity
Mar 9, 2026
Reiterates: Outperform
Price Target: $44
Current: $24.57
Upside: +79.08%
IQVIA Holdings
Mar 3, 2026
Initiates: Outperform
Price Target: $221
Current: $158.98
Upside: +39.01%
Medline
Feb 26, 2026
Maintains: Outperform
Price Target: $47$53
Current: $44.24
Upside: +19.80%
Evolent Health
Feb 25, 2026
Maintains: Sector Perform
Price Target: $5$3
Current: $3.62
Upside: -17.13%
Privia Health Group
Jan 9, 2026
Reinstates: Outperform
Price Target: $31
Current: $24.84
Upside: +24.80%
TruBridge
Jan 9, 2026
Reinstates: Sector Perform
Price Target: $23
Current: $25.73
Upside: -10.61%
The Ensign Group
Apr 28, 2017
Downgrades: Underperform
Price Target: n/a
Current: $188.30
Upside: -